Company Profiles

driven by the PitchBook Platform

Athenex

Description

Developer of novel therapies created to treat cancer. The company focuses on the development and commercialization of therapies for cancer and immunomodulatory diseases, by improving the lives of cancer patients by creating more effective, safer and tolerable treatments.

2002

Founded

IPO REG.

Status

201-500

Employees

IPO

Latest Deal Type

$100M

Latest Deal Amount

$258M

Total Amount Raised

Description

Developer of novel therapies created to treat cancer. The company focuses on the development and commercialization of therapies for cancer and immunomodulatory diseases, by improving the lives of cancer patients by creating more effective, safer and tolerable treatments.

Website:

www.athenex.com

Formerly Known As

Kinex Pharmaceuticals

Ownership Status

In IPO registration

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

1001 Main Street Suite 600 Buffalo, NY 14203United States +1 (716) 427-2950
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Athenex's full profile, request a free trial.

Athenex Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Athenex Investors (9)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Charter Link InternationalOtherMinority000 0000000 0000
Erie County Industrial Development AgencyGovernmentMinority000 0000000 0000
Huateng MaAngel (individual)Minority000 0000000 0000
John R. Oishei FoundationCorporationMinority000 0000000 0000
Mandra CapitalVenture CapitalMinority000 0000000 0000
Charter Link International Other
Erie County Industrial Development Agency Government
Huateng Ma Angel (individual)
John R. Oishei Foundation Corporation
Mandra Capital Venture Capital

Athenex Executive Team (20)

NameTitleBoard
Seat
Contact
Info
Johnson Lau MDChief Executive Officer & Board Chairman
Stephen Panaro Ph.DPresident
William Zuo Ph.DPresident of Polymed Therapeutics
Jeffrey YordonChief Operating Officer
David Hangauer Ph.DChief Scientific Officer & Co-Founder
Johnson Lau MD Chief Executive Officer & Board Chairman
Stephen Panaro Ph.D President
William Zuo Ph.D President of Polymed Therapeutics
Jeffrey Yordon Chief Operating Officer
David Hangauer Ph.D Chief Scientific Officer & Co-Founder

Athenex Board Members (6)

NameRepresentingRoleSinceContact
Info
Antony LeungAthenexBoard Member000 0000
Jinn Wu Ph.DSelfBoard Member000 0000
Johnson Lau MDAthenexChief Executive Officer & Board Chairman000 0000
Kim CampbellAthenexBoard Member000 0000
Manson FokAthenexBoard Member000 0000
Antony Leung Board Member Athenex
Jinn Wu Ph.D Board Member Self
Johnson Lau MD Chief Executive Officer & Board Chairman Athenex
Kim Campbell Board Member Athenex
Manson Fok Board Member Athenex
Request full access to PitchBook